PAPER Lowe VJ, Lundt ES, Albertson SM, Przybelski SA, Senjem ML, Parisi JE, Kantarci K, Boeve B, Jones DT, Knopman D, Jack CR Jr, Dickson DW, Petersen RC, Murray ME
SEARCH RESULTS
310 RESULTS
PAPER Vatanabe IP, Manzine PR, Cominetti MR
Historic concepts of dementia and Alzheimer's disease: From ancient times to the present.
Rev Neurol (Paris). 2019 Jun 4; PubMed: 31174886PAPER Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, Fekrat S
Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants.
Ophthalmol Retina. 2019 Jun;3(6):489-499. Epub 2019 Mar 11 PubMed: 31174670PAPER Zhang S, Zhao J, Zhang Y, Zhang Y, Cai F, Wang L, Song W
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease.
Alzheimers Res Ther. 2019 Jun 7;11(1):54. PubMed: 31174614PAPER Latimer CS, Burke BT, Liachko NF, Currey HN, Kilgore MD, Gibbons LE, Henriksen J, Darvas M, Domoto-Reilly K, Jayadev S, Grabowski TJ, Crane PK, Larson EB, Kraemer BC, Bird TD, Keene CD
Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Acta Neuropathol Commun. 2019 Jun 7;7(1):91. PubMed: 31174609PAPER Márquez F, Yassa MA
Neuroimaging Biomarkers for Alzheimer's Disease.
Mol Neurodegener. 2019 Jun 7;14(1):21. PubMed: 31174557Alan Peter
United States
Davor Ivankovic
UCL
PAPER Sun F, Deng Y, Han X, Liu Q, Zhang P, Manzoor R, Ma H
A secret that underlies Parkinson's disease: The damaging cycle.
Neurochem Int. 2019 Oct;129:104484. Epub 2019 Jun 4 PubMed: 31173779PAPER Katsu M, Hama Y, Utsumi J, Takashina K, Yasumatsu H, Mori F, Wakabayashi K, Shoji M, Sasaki H
MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis.
Neurosci Lett. 2019 Aug 24;708:134176. Epub 2019 Jun 4 PubMed: 31173847PAPER Saito T, Oba T, Shimizu S, Asada A, Iijima KM, Ando K
Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
Hum Mol Genet. 2019 Sep 15;28(18):3062-3071. PubMed: 31174206PAPER Sagar SR, Singh DP, Das RD, Panchal NB, Sudarsanam V, Nivsarkar M, Vasu KK
Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer's disease.
Bioorg Chem. 2019 Aug;89:102992. Epub 2019 May 22 PubMed: 31174042PAPER Boztas M, Taslimi P, Yavari MA, Gulcin I, Sahin E, Menzek A
Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: Ring opening of cyclopropane with monoester.
Bioorg Chem. 2019 Aug;89:103017. Epub 2019 May 28 PubMed: 31174041PAPER Atmaca U, Kaya R, Karaman HS, Çelik M, Gülçin İ
Synthesis of oxazolidinone from enantiomerically enriched allylic alcohols and determination of their molecular docking and biologic activities.
Bioorg Chem. 2019 Jul;88:102980. Epub 2019 May 9 PubMed: 31174010PAPER de Bari L, Atlante A, Armeni T, Kalapos MP
Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer's disease. Exploring the crossroad of eternal youth and premature aging.
Ageing Res Rev. 2019 Aug;53:100915. Epub 2019 Jun 4 PubMed: 31173890Current Filters
- Date Range : Jun 2019 to Jun 2019 x